Oysters linked to norovirus outbreak, FDA says abc15
The FDA confirmed the potentially contaminated oysters were distributed in several states. The states include California, Colorado, Florida, Hawaii, Illinois, Massachusetts, Minnesota, New Jersey, Nevada, Oregon, Texas and Washington.Retails are advised not to serve or sell oysters harvested from the following locations:Norovirus symptoms
People with norovirus can feel extremely ill, the FDA said and can vomit or have diarrhea many times a day. That can lead to dehydration, especially in young children, older adults or people with other illnesses.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA warns of raw oysters potentially contaminated with norovirusThe FDA is warning consumers of raw oysters from British Columbia potentially contaminated with norovirus.
Read more »
Raw oysters possibly contaminated with norovirus sold in multiple states, including Florida, FDA warnsThe FDA is investigating a multi-state norovirus outbreak linked to potentially contaminated raw oysters sold in at least 13 states, including Florida.
Read more »
Oysters linked to norovirus outbreak were sent to N.J. retailers, restaurants, FDA saysThe most common symptoms of norovirus are diarrhea, vomiting, nausea, and stomach pain, health officials said.
Read more »
Scientists Divided on Need for 4th Covid Shot After FDA Quietly Approved Another Round of BoostersThe FDA's top vaccine regulator Dr. Peter Marks said shortly after the decision that another round of boosters will likely be needed in the fall.
Read more »
Current COVID vaccines not 'well-matched' against BA.2 -FDAThe FDA, however, said booster shots protect against serious outcomes of COVID-19, compared with the two preliminary doses. U.S. health officials in late March authorized a second booster dose of Moderna and Pfizer's vaccines for people aged 50 and older, citing data showing waning immunity and risks posed by Omicron variants of the virus. 'This discussion today is a much larger discussion - it's a discussion for what do we do about the entire population, and what do we do when we think the virus has evolved further,' said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
Read more »